Qualitative Concept – Page 40

Pfizer Terminates Hemophilia A Gene Therapy Partnership with Sangamo, Citing Commercial Viability Concerns

9 months ago talkbio0Tagged commercial, gene therapy, Hemophilia A, partnership termination, Pfizer, Viable

Pfizer, Sangamo Therapeutics, Hemophilia A, Gene Therapy, Commercial Viability, Partnership Termination

Axsome to Pursue FDA Approval for Alzheimer’s Agitation Treatment Despite Mixed Trial Results

9 months ago talkbio0Tagged Alzheimer 's disease, Approved, AXS 05, Axsome, mixed trial, United States Food and Drug Administration

Axsome Therapeutics, Alzheimer’s disease agitation, FDA approval, mixed trial data, AXS-05

FDA Approves Subcutaneous Formulation of Bristol Myers’ Opdivo for Solid Tumor Indications

9 months ago talkbio0Tagged Approved, Cancer Therapeutic Procedure, hyaluronidase, Immunotherapy, Myers, nivolumab, squibb, Subcutaneous Opdivo, United States Food and Drug Administration

FDA approval, subcutaneous Opdivo, Bristol Myers Squibb, cancer treatment, immunotherapy, nivolumab, hyaluronidase

Eli Lilly’s Zepbound Receives FDA Approval as First Prescription Drug for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

9 months ago talkbio0Tagged Approved, Glucagon-Like Peptide 1, Obesity, Sleep Apnea, Obstructive, tirzepatide, United States Food and Drug Administration, Zepbound

GLP-1, Obstructive Sleep Apnea (OSA), Obesity, Zepbound, Tirzepatide, FDA Approval, Sleep Disorder Treatment

Cobenfy: A Breakthrough in Schizophrenia Treatment with a Novel Mechanism of Action

9 months ago talkbio0Tagged Antipsychotic Agents, Approved, Cobenfy, Muscarinic Acetylcholine Receptor, Myers, Schizophrenia, squibb, trospium chloride, United States Food and Drug Administration, xanomeline

Cobenfy, schizophrenia, muscarinic receptors, xanomeline, trospium chloride, Bristol Myers Squibb, Karuna Therapeutics, FDA approval, antipsychotic drugs.

FDA Approves Zepbound for Obstructive Sleep Apnea in Adults with Obesity

9 months ago talkbio0Tagged Approved, Obesity, Sleep Apnea, Obstructive, United States Food and Drug Administration, Zepbound

Zepbound, FDA approval, obstructive sleep apnea, obesity, tirzepatide, sleep disorder treatment

AstraZeneca’s Tagrisso Expands EU Approval for NSCLC Treatment

9 months ago talkbio0Tagged Approved, AstraZeneca, Epidermal Growth Factor Receptor, EU, Malignant neoplasm of lung, Mutation, Non-Small Cell Lung Carcinoma, Tagrisso

AstraZeneca, Tagrisso, NSCLC, EU approval, EGFR mutations, lung cancer treatment

FDA Approves ALYFTREK, a Next-Generation CFTR Modulator for Cystic Fibrosis Treatment

9 months ago talkbio0Tagged ALYFTREK, Approved, CFTR, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Modulator Device, once-daily, United States Food and Drug Administration

ALYFTREK, cystic fibrosis, CFTR modulator, FDA approval, once-daily treatment, Vertex Pharmaceuticals

FDA Approves Alhemo: A Breakthrough Once-Daily Treatment for Hemophilia A and B with Inhibitors

9 months ago talkbio0Tagged Alhemo, Approved, concizumab, Hemophilia A, Hemophilia B, inhibitors, once-daily, Prophylactic treatment, subcutaneous, United States Food and Drug Administration

Alhemo, FDA approval, hemophilia A, hemophilia B, inhibitors, concizumab, once-daily treatment, subcutaneous injection, prophylactic treatment

Eli Lilly’s Zepbound Wins Historic FDA Approval for Treating Obstructive Sleep Apnea in Adults with Obesity

9 months ago talkbio0Tagged Approved, Obesity, Sleep Apnea, Obstructive, United States Food and Drug Administration, Zepbound

Zepbound, tirzepatide, FDA approval, obstructive sleep apnea, obesity, weight loss, sleep disorder treatment